Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide

NCT00213031 is registered in ClinicalTrials.gov with Population Council as lead sponsor.

NCT NCT00213031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00213031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide
Lead sponsor
Population Council
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2000
Completion date
December 31, 2001
Enrollment
165
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis, herpes simplex, hiv infections, neisseria gonorrhoeae, syphilis, trichomonas vaginitis